Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab-Reference-Cited by-同舟云学术

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Published:2016-05-16 Issue:22 Volume:22 Page:5487-5496
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Weide Benjamin,Martens Alexander,Hassel Jessica C.,Berking Carola,Postow Michael A.,Bisschop Kees,Simeone Ester,Mangana Johanna,Schilling Bastian,Di Giacomo Anna Maria,Brenner Nicole,Kähler Katharina,Heinzerling Lucie,Gutzmer Ralf,Bender Armin,Gebhardt Christoffer,Romano Emanuela,Meier Friedegund,Martus Peter,Maio Michele,Blank Christian,Schadendorf Dirk,Dummer Reinhard,Ascierto Paolo A.,Hospers Geke,Garbe Claus,Wolchok Jedd D.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 479 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of T Helper 2-Type Inflammatory Diseases Following Immune Checkpoint Inhibitor Treatment;Biomedicines;2024-08-19

2. Prognostic value of a novel myeloid-to-lymphoid ratio biomarker in advanced gastric cancer;Clinical and Translational Oncology;2024-08-14

3. Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab;Acta Oncologica;2024-08-11

4. Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25);Clinical Genitourinary Cancer;2024-08

5. PD-1 negatively regulates helper T cell differentiation into Th2;2024-07-26